Trial NCT00433017

View at ClinicalTrials.gov 
Org. Study IDs: CBPD952A2309

Last trial update was posted on 2011-04-21

MeSH Interventions

Ranibizumab Verteporfin

MeSH Conditions

Choroidal Neovascularization Macular Degeneration Neovascularization, Pathologic

Other Conditions


Stopping Reasons

Study was terminated based on the results of analyses performed as planned at Month 12.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID